Point-of-Care Cardiac Troponin Testing

This publication has 12 references indexed in Scilit:

• Validation of the 99th Percentile Cutoff Independent of Assay Imprecision (CV) for Cardiac Troponin Monitoring for Ruling Out Myocardial Infarction
  Clinical Chemistry, 2005
• Reducing Laboratory Turnaround Time Outliers Can Reduce Emergency Department Patient Length of Stay
  American Journal of Clinical Pathology, 2005
• Practical Implementation of the Guidelines for Unstable Angina/Non–ST-Segment Elevation Myocardial Infarction in the Emergency Department
  Circulation, 2005
• Rates of Positive Cardiac Troponin I and Creatine Kinase MB Mass among Patients Hospitalized for Suspected Acute Coronary Syndromes
  Clinical Chemistry, 2004
• Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus Recommendations
  Clinical Chemistry, 2003
• Prognostic Value of the Ortho Vitros Cardiac Troponin I Assay in Patients With Symptoms of Myocardial Ischemia
  American Journal of Clinical Pathology, 2003
• European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials
  American Heart Journal, 2002
• Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial InfarctionResults From a Randomized Trial
  JAMA, 2001
• Bedside Multimarker Testing for Risk Stratification in Chest Pain Units
  Circulation, 2001
• It’s Time for a Change to a Troponin Standard
  Circulation, 2000